New Side Affect???
Husband is on his 13th chemo cycle of Gemcitabine and Abraxane for stage 4 pancreatic cancer. His last CT was very good. Tumors shrinking smaller than a cm and nothing new.
He had Whipple surgery 2 years ago. He has started to "drip" (pee) during the night and needs to wear protection. This started about 3 weeks ago after chemo treatment. Is this another chemo side affect? Oncology doc doesn't know.......Anyone else have this?
Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.
How old is your husband? Has he had prostate problems or surgery?
He had the Whipple surgery 2 years ago. No prostate problems. He's 68.
I did not experience that during my treatment, but Dr. Google indicates that urinary incontinence can be a (rare) result of Gem/Abrax chemo, sometimes associated with bladder inflammation (cystitis).
Sorry for the long cut-and-paste answer below, but here's what I got from pasting "urinary incontinence abraxane gemcitabine chemotherapy" into the Google search bar:
AI Overview:
Urinary incontinence is an uncommon side effect of the chemotherapy combination of Abraxane (nab-paclitaxel) and gemcitabine. The risk is generally low, but it can occur. Both drugs are used to treat various cancers, including pancreatic cancer.
Abraxane
Uncommon side effect: Urinary incontinence is an uncommon (0.1% to 1%) genitourinary side effect of Abraxane.
Neuropathy: The drug is more commonly known to cause peripheral neuropathy, or nerve damage, which can lead to numbness or tingling in the hands and feet. In rare instances, nerve damage caused by chemotherapy can affect the nerves that control the bladder, potentially leading to incontinence.
Gemcitabine
Bladder irritation: When given intravesically (directly into the bladder) for bladder cancer, gemcitabine can cause temporary symptoms like an increased urge and frequency of urination. In systemic (intravenous) chemotherapy, gemcitabine can also cause bladder inflammation (cystitis).
Combination therapy: A case study reported urinary incontinence in a patient receiving a combination of gemcitabine and docetaxel, suggesting a possible link to chemotherapy-induced nerve damage impacting bladder function. While this study did not involve Abraxane, it highlights how multi-drug chemotherapy regimens can sometimes affect bladder control.
Contributing factors to incontinence
The Canadian Cancer Society notes that urinary incontinence during chemotherapy can be caused by:
Nerve damage: Certain chemotherapy drugs can harm the nerves that control the bladder.
Bladder inflammation: High-dose chemotherapy can cause inflammation of the bladder lining.
Other side effects: Related side effects such as vomiting and diarrhea can also contribute to a loss of bladder control.
Management and prognosis
If you experience urinary incontinence during your chemotherapy treatment, notify your medical team immediately.
Management often involves drinking plenty of fluids to flush the bladder and may include medication or other strategies to help with bladder control.
For many patients, incontinence may improve as the body recovers after treatment.
However, sometimes the condition can be permanent, particularly if nerve damage has occurred.
Abraxane Side Effects: Common, Severe, Long Term
Sep 27, 2024 — Genitourinary * Common (1% to 10%): Urinary tract infection. * Uncommon (0.1% to 1%): Dysuria, pollakiuria, hematuria, nocturia, polyuria, urinary incontinence,
favicon
Drugs.com
Urinary incontinence | Canadian Cancer Society
Urinary incontinence after some cancer treatments may gradually get better as the body recovers. Sometimes urinary incontinence is permanent. Radiation therapy ...
favicon
Canadian Cancer Society
Gemcitabine and nab-paclitaxel (Abraxane®)
Some people may have side effects while they are being given the chemotherapy or shortly after they have it: * Allergic reaction. Some people have an allergic r...
favicon
Macmillan Cancer Support
Show all
Dive deeper in AI Mode...